NYSE:ZBH Zimmer Biomet (ZBH) Stock Price, News & Analysis $101.22 -0.25 (-0.25%) Closing price 11/20/2026 03:59 PM EasternExtended Trading$100.98 -0.24 (-0.24%) As of 11/20/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Zimmer Biomet Stock (NYSE:ZBH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Zimmer Biomet alerts:Sign Up Key Stats Today's Range$100.82▼$103.8750-Day Range$87.98▼$109.4652-Week Range$79.12▼$112.54Volume2.96 million shsAverage Volume2.64 million shsMarket Capitalization$19.16 billionP/E Ratio25.62Dividend Yield0.95%Price Target$114.32Consensus RatingHold Company Overview Zimmer Biomet Holdings, Inc. develops and manufactures medical devices and technologies used in musculoskeletal care. Its products support orthopedic procedures involving the hip, knee, shoulder, and extremities, as well as trauma care, sports medicine, and related surgical applications. The company also offers surgical technologies, including robotic and digital solutions designed to assist clinicians with planning and performing procedures. Its products and services are used by hospitals, surgeons, and other healthcare providers. Headquartered in Warsaw, Indiana, Zimmer Biomet traces its history to Zimmer, founded in 1927. The company took its current form in 2015, when Zimmer completed its acquisition of Biomet. It serves healthcare markets around the world, and Ivan Tornos became president and chief executive officer in 2023.AI Generated. May Contain Errors. Read More Zimmer Biomet Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks75th Percentile Overall ScoreZBH MarketRank™: 3.7480734202 of 5 starsZimmer Biomet scored higher than 75% of companies evaluated by MarketBeat, and ranked 80th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingZimmer Biomet has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on no strong buy ratings, 8 buy ratings, 15 hold ratings, and 1 sell rating.Upside PotentialZimmer Biomet has a consensus price target of $114.32, representing about 12.9% upside from its current price of $101.22.Amount of Analyst CoverageZimmer Biomet has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Zimmer Biomet's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth3.97% Earnings GrowthEarnings for Zimmer Biomet are expected to grow by 3.97% in the coming year, from $8.56 to $8.90 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Zimmer Biomet is 25.62, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.19.Price to Earnings Ratio vs. SectorThe P/E ratio of Zimmer Biomet is 25.62, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.56.Price to Earnings Growth RatioZimmer Biomet has a PEG Ratio of 2.37. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioZimmer Biomet has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Zimmer Biomet's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.17% of the float of Zimmer Biomet has been sold short.Short Interest Ratio / Days to CoverZimmer Biomet has a short interest ratio ("days to cover") of 3.89, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Zimmer Biomet has recently decreased by 1.40%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldZimmer Biomet has a dividend yield of 0.95%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthZimmer Biomet does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Zimmer Biomet is 24.30%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Zimmer Biomet will have a dividend payout ratio of 10.79% next year. This indicates that Zimmer Biomet will be able to sustain or increase its dividend.Read more about Zimmer Biomet's dividend. News and Social Media3.5 / 5News Sentiment0.57 News SentimentZimmer Biomet has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 20 news articles for Zimmer Biomet this week, compared to 5 articles on an average week.Search Interest5 people have searched for ZBH on MarketBeat in the last 30 days. MarketBeat FollowsOnly 2 people have added Zimmer Biomet to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Zimmer Biomet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $824,028.00 in company stock.Percentage Held by Insiders1.28% of the stock of Zimmer Biomet is held by insiders.Percentage Held by Institutions88.89% of the stock of Zimmer Biomet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Zimmer Biomet's insider trading history. Receive ZBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZBH Stock News HeadlinesZimmer Biomet: Fixing Its Own House While Its Rivals Are DistractedNovember 21 at 11:00 PM | seekingalpha.comZimmer Biomet: Solid Sales And Cash Flow Drive A BuyNovember 21 at 5:00 AM | seekingalpha.comCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.November 22 at 1:00 AM | Decentralized Masters (Ad)Is Zimmer Biomet Holdings (ZBH) Fairly Valued After Its Surgeon Guided Autonomy Rollout?November 19 at 8:08 PM | finance.yahoo.comCan Zimmer Biomet Holdings (ZBH) Stay Cheap If Cash Flow Delivers?November 19 at 8:08 PM | finance.yahoo.comZimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference TranscriptNovember 19 at 3:07 PM | seekingalpha.comZimmer Biomet (NYSE:ZBH) Stock Rating Upgraded by Wells Fargo & CompanyNovember 19 at 2:30 AM | americanbankingnews.comBMO Capital Markets Issues Pessimistic Forecast for Zimmer Biomet (NYSE:ZBH) Stock PriceNovember 18, 2026 | americanbankingnews.comSee More Headlines ZBH Stock Analysis - Frequently Asked Questions How have ZBH shares performed this year? Zimmer Biomet's stock was trading at $89.94 at the start of the year. Since then, ZBH shares have increased by 12.5% and is now trading at $101.2180. How were Zimmer Biomet's earnings last quarter? Zimmer Biomet Holdings, Inc. (NYSE:ZBH) released its quarterly earnings data on Wednesday, November, 4th. The medical equipment provider reported $1.90 earnings per share for the quarter, topping the consensus estimate of $1.88 by $0.02. The business's revenue was up 3.1% on a year-over-year basis. Read the conference call transcript. Does Zimmer Biomet have any subsidiaries? Zimmer Biomet subsidiaries include Respondwell, Clinical Graphics, CD Diagnostics, Medtech SAS, Compression Therapy Products, LDR Holding, Cayenne Medical, and more. Who are Zimmer Biomet's major shareholders? Top institutional shareholders of Zimmer Biomet include Dodge & Cox (12.01%), State Street Corp (4.69%), American Century Companies Inc. (1.25%) and Equity Investment Corp (0.93%). Insiders that own company stock include Chad F Phipps, Sang Yi and Lori Winkler. View institutional ownership trends. How do I buy shares of Zimmer Biomet? Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Zimmer Biomet own? Based on aggregate information from My MarketBeat watchlists, some other companies that Zimmer Biomet investors own include NVIDIA (NVDA), Bristol Myers Squibb (BMY), Pfizer (PFE), Salesforce (CRM), Walt Disney (DIS), Intel (INTC) and JPMorgan Chase & Co. (JPM). Company Calendar Record date for 10/30 Dividend9/30/2026Ex-Dividend for 10/30 Dividend9/30/2026Dividend Payable10/30/2026Last Earnings11/04/2026Today11/22/2026Fiscal Year End12/31/2026Next Earnings (Estimated)2/09/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ZBH's financial health is in the Green zone, according to TradeSmith. ZBH has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:ZBH Previous SymbolNYSE:ZMH CIK1136869 Webwww.zimmerbiomet.com Phone(574) 267-6131Fax574-372-4988Employees17,000Year Founded1927Price Target and Rating Average Price Target for Zimmer Biomet$114.32 High Price Target$140.00 Low Price Target$93.00 Potential Upside/Downside+12.9%Consensus RatingHold Rating Score (0-4)2.29 Research Coverage24 Analysts Profitability EPS (Trailing Twelve Months)$3.95 Trailing P/E Ratio25.62 Forward P/E Ratio11.37 P/E Growth2.37Net Income$705.20 million Net Margins8.95% Pretax Margin10.32% Return on Equity13.02% Return on Assets7.17% Debt Debt-to-Equity Ratio0.49 Current Ratio1.46 Quick Ratio0.79 Sales & Book Value Annual Sales$8.23 billion Price / Sales2.33 Cash Flow$13.75 per share Price / Cash Flow7.36 Book Value$67.24 per share Price / Book1.51Miscellaneous Outstanding Shares189,250,000Free Float186,832,000Market Cap$19.16 billion OptionableOptionable Beta0.50 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NYSE:ZBH) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersPrediction: NVDA will “snap back” on this dateOthers paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access f...Base Camp Trading | SponsoredYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredGold Miners Post Record Cash Flows as AI Stocks WobbleGold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | SponsoredNoah’s Ark found?Scientists may have discovered Noah's Ark buried under a mountain in eastern Turkey, just two miles from the I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zimmer Biomet Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zimmer Biomet With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.